Advertisement
Screener

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

1.6 / 5 stars · 37/115 Roast Me

INTEGRA LIFESCIENCES HOLDINGS CORP Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$9.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-29

  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$9.26M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$863.00K, a 124.91% decline year-over-year.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $1.90M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$1.07M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$2.51M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$12.46M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$25.37M, a 145.78% decline from fiscal 2022.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $55.42M, a 91.74% increase from fiscal 2021.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2026-06-30-$9.26M
10-Q · filed 2026-07-29
-$10.12M
10-Q · filed 2026-07-29
-$8.22M
derived: sum of 3 quarters · filed 2026-07-29
-$9.29M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$863.00K
10-Q · filed 2026-07-29
$1.03M
derived: sum of 2 quarters · filed 2026-07-29
-$33.00K
derived: sum of 3 quarters · filed 2026-07-29
-$6.83M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$830.00K
derived: sum of 2 quarters · filed 2026-02-26
-$5.97M
derived: sum of 3 quarters · filed 2026-07-29
-$2.51M
10-K · filed 2026-02-26
2025-09-30-$1.07M
10-Q · filed 2025-10-30
-$7.87M
derived: sum of 2 quarters · filed 2026-07-29
-$4.40M
10-Q · filed 2025-10-30
-$7.12M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$6.80M
10-Q · filed 2026-07-29
-$3.34M
10-Q · filed 2025-07-31
-$6.05M
derived: sum of 3 quarters · filed 2026-07-29
-$12.18M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$3.46M
10-Q · filed 2026-07-29
$748.00K
derived: sum of 2 quarters · filed 2026-07-29
-$5.38M
derived: sum of 3 quarters · filed 2026-07-29
-$13.46M
derived: sum of 4 quarters · filed 2026-07-29
2024-12-31-$2.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$8.85M
derived: sum of 2 quarters · filed 2026-02-26
-$16.93M
derived: sum of 3 quarters · filed 2026-02-26
-$12.46M
10-K · filed 2026-02-26
2024-09-30-$6.13M
10-Q · filed 2025-10-30
-$14.21M
derived: sum of 2 quarters · filed 2025-10-30
-$9.75M
10-Q · filed 2024-11-04
-$26.60M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$8.08M
10-Q · filed 2025-10-30
-$3.62M
10-Q · filed 2024-07-29
-$20.47M
derived: sum of 3 quarters · filed 2026-02-26
-$23.56M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$4.46M
10-Q · filed 2025-10-30
-$12.39M
derived: sum of 2 quarters · filed 2026-02-26
-$15.48M
derived: sum of 3 quarters · filed 2026-02-26
-$17.71M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$16.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$19.94M
derived: sum of 2 quarters · filed 2026-02-26
-$22.17M
derived: sum of 3 quarters · filed 2026-02-26
-$25.37M
10-K · filed 2026-02-26
2023-09-30-$3.08M
10-Q · filed 2024-11-04
-$5.32M
derived: sum of 2 quarters · filed 2024-11-04
-$8.52M
10-Q · filed 2023-10-25
$9.18M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30-$2.24M
10-Q · filed 2024-11-04
-$5.43M
10-Q · filed 2023-07-27
$12.27M
derived: sum of 3 quarters · filed 2025-02-25
$18.05M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$3.20M
10-Q · filed 2024-11-04
$14.51M
derived: sum of 2 quarters · filed 2025-02-25
$20.28M
derived: sum of 3 quarters · filed 2025-02-25
$28.09M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$17.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$23.48M
derived: sum of 2 quarters · filed 2025-02-25
$31.29M
derived: sum of 3 quarters · filed 2025-02-25
$55.42M
10-K · filed 2025-02-25
2022-09-30$5.78M
10-Q · filed 2023-10-25
$13.59M
derived: sum of 2 quarters · filed 2023-10-25
$37.72M
10-Q · filed 2022-10-26
$39.34M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$7.81M
10-Q · filed 2023-10-25
$31.94M
10-Q · filed 2022-07-27
$33.56M
derived: sum of 3 quarters · filed 2024-02-28
$36.75M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$24.13M
10-Q · filed 2023-10-25
$25.75M
derived: sum of 2 quarters · filed 2024-02-28
$28.94M
derived: sum of 3 quarters · filed 2024-02-28
$22.60M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$4.81M
derived: sum of 2 quarters · filed 2024-02-28
-$1.53M
derived: sum of 3 quarters · filed 2024-02-28
$28.90M
10-K · filed 2024-02-28
2021-09-30$3.19M
10-Q · filed 2022-10-26
-$3.15M
derived: sum of 2 quarters · filed 2022-10-26
$27.29M
10-Q · filed 2021-11-02
$45.14M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$6.34M
10-Q · filed 2022-10-26
$24.10M
10-Q · filed 2021-07-29
$41.95M
derived: sum of 3 quarters · filed 2023-02-22
$53.16M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$30.43M
10-Q · filed 2022-10-26
$48.29M
derived: sum of 2 quarters · filed 2023-02-22
$59.50M
derived: sum of 3 quarters · filed 2023-02-22
$60.96M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$17.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$29.07M
derived: sum of 2 quarters · filed 2023-02-22
$30.53M
derived: sum of 3 quarters · filed 2023-02-22
$2.34M
10-K · filed 2023-02-22
2020-09-30$11.21M
10-Q · filed 2021-11-02
$12.68M
derived: sum of 2 quarters · filed 2021-11-02
-$15.51M
10-Q · filed 2020-10-29
-$4.30M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$1.46M
10-Q · filed 2021-11-02
-$26.72M
10-Q · filed 2020-08-10
-$15.51M
derived: sum of 3 quarters · filed 2022-02-24
-$34.42M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$28.19M
10-Q · filed 2021-11-02
-$16.97M
derived: sum of 2 quarters · filed 2022-02-24
-$35.89M
derived: sum of 3 quarters · filed 2022-02-24
-$47.91M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$11.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$7.70M
derived: sum of 2 quarters · filed 2022-02-24
-$19.72M
derived: sum of 3 quarters · filed 2022-02-24
-$30.96M
10-K · filed 2022-02-24
2019-09-30-$18.91M
10-Q · filed 2020-10-29
-$30.94M
derived: sum of 2 quarters · filed 2020-10-29
-$42.17M
10-Q · filed 2019-10-25
-$61.88M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30-$12.02M
10-Q · filed 2020-10-29
-$23.26M
10-Q · filed 2019-07-25
-$42.96M
derived: sum of 3 quarters · filed 2021-02-23
-$43.93M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31-$11.24M
10-Q · filed 2020-10-29
-$30.94M
derived: sum of 2 quarters · filed 2021-02-23
-$31.91M
derived: sum of 3 quarters · filed 2021-02-23
-$54.48M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31-$19.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
-$20.67M
derived: sum of 2 quarters · filed 2021-02-23
-$43.25M
derived: sum of 3 quarters · filed 2021-02-23
-$21.64M
10-K · filed 2021-02-23
2018-09-30-$965.00K
10-Q · filed 2019-10-25
-$23.54M
derived: sum of 2 quarters · filed 2019-10-25
-$1.93M
10-Q · filed 2019-10-25
-$1.93M
10-Q · filed 2018-11-01
-$1.96M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30-$22.58M
10-Q · filed 2019-07-25
-$967.00K
10-Q · filed 2018-07-26
-$990.00K
derived: sum of 3 quarters · filed 2020-02-21
$9.38M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$21.61M
10-Q · filed 2019-07-25
$21.59M
derived: sum of 2 quarters · filed 2020-02-21
$31.96M
derived: sum of 3 quarters · filed 2020-02-21
$49.26M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$10.35M
derived: sum of 2 quarters · filed 2020-02-21
$27.65M
derived: sum of 3 quarters · filed 2020-02-21
$33.35M
10-K · filed 2020-02-21
2017-09-30$10.38M
10-Q · filed 2018-11-01
$27.67M
derived: sum of 2 quarters · filed 2018-11-01
$33.37M
10-Q · filed 2017-10-26
2017-06-30$17.30M
10-Q · filed 2018-11-01
$23.00M
10-Q · filed 2017-07-26
2017-03-31$5.70M
10-Q · filed 2018-11-01
$1.29M
10-Q · filed 2017-04-26
2016-12-31-$9.25M
10-K · filed 2019-02-26
2015-12-31-$24.41M
10-K · filed 2018-03-01
2014-12-31-$24.41M
10-K · filed 2017-02-23
2013-12-31$5.72M
10-K · filed 2016-02-26
2012-12-31$4.30M
10-K · filed 2015-02-27
2011-12-31-$7.30M
8-K · filed 2014-06-20
2010-12-31-$10.70M
10-K · filed 2013-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92